Cellectis slides after FDA placed clinical hold on MELANI-01 study following fatal adverse event Check out this evening's top movers from around Wall Street, compiled by The Fly.
HIGHER -
- Otonomy (OTIC) up 22.0% after Phase 3 update on Otividex program
- XpresSpa (XSPA) up 12.4% after Q2 business update
- Chembio Diagnostics (CEMI) up 11.2% after being awarded BARDA contract for DPP COVID point of care antigen system
- Great Lakes Dredge (GLDD) up 10.4% after getting 51.1M in dredging awards
- Parsons (PSN) up 4.1% after announcing $178M contract by intelligence community
- Kingstone Companies (KINS) up 3.9% after guiding Q2 earnings
DOWN AFTER EARNINGS
-
- Remark Holdings (MARK) down 17.0%
ALSO LOWER -
- Cellectis (CLLS) down 13.4% after FDA placed clinical hold on MELANI-01 study
- Trinity Biotech (TRIB) down 4.3% after mixed shelf offering
- Revolution Medicines (RVMD) down 3.3% after equity offering
- Pacira (PCRX) down 2.9% after convertible debt offering, preliminary Q2 revenue
- Alexandria Real Estate Equities (ARE) down 2.0% after equity offering
- Kinder Morgan (KMI) down 1.3% after being cut to Sell at Goldman Sachs
Symbols:
OTIC XSPA CEMI GLDD PSN KINS MARK CLLS TRIB RVMD PCRX ARE KMI Keywords: fly intel, wall street, afterhours, movers, top stories, stocks, cellectis